Private equity exit pressure and secondary markets reshape liquidity
Weak distributions, aging NAV, tighter lending, elevated rates, and the 2028–2029 maturity wall keep exit readiness and leverage discipline central. Broad-market commentary cites 33,853 unsold investments, holding periods near seven years, and distributions at 12% of beginning NAV versus a historical norm near 20%; these are not healthcare-specific realized performance. T. Rowe Price’s 2027 outlook favors selective structured capital, secondaries, and infrastructure, not evidence of healthcare deal returns.
Sources (6)
Updated Nov 18, 2026